Literature DB >> 18817513

Novel drug delivery systems for inner ear protection and regeneration after hearing loss.

Rachael T Richardson1, Andrew K Wise, Jacqueline K Andrew, Stephen J O'Leary.   

Abstract

BACKGROUND: A cochlear implant, the only current treatment for restoring auditory perception after severe or profound sensorineural hearing loss (SNHL), works by electrically stimulating spiral ganglion neurons (SGNs). However, gradual degeneration of SGNs associated with SNHL can compromise the efficacy of the device.
OBJECTIVE: To review novel drug delivery systems for preserving and/or regenerating sensory cells in the cochlea after SNHL.
METHODS: The effectiveness of traditional cochlear drug delivery systems is compared to newer techniques such as cell, polymer and gene transfer technologies. Special requirements for local drug delivery to the cochlea are discussed, such as protecting residual hearing and site-specific drug delivery for cell preservation and regeneration. RESULTS/
CONCLUSIONS: Drug delivery systems with the potential for immediate clinical translation, as well as those that will contribute to the future of hearing preservation or cochlear cellular regeneration, are identified.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18817513     DOI: 10.1517/17425247.5.10.1059

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  12 in total

1.  AAV-Mediated Neurotrophin Gene Therapy Promotes Improved Survival of Cochlear Spiral Ganglion Neurons in Neonatally Deafened Cats: Comparison of AAV2-hBDNF and AAV5-hGDNF.

Authors:  Patricia A Leake; Stephen J Rebscher; Chantale Dore'; Omar Akil
Journal:  J Assoc Res Otolaryngol       Date:  2019-06-20

2.  Dual Release Carriers for Cochlear Delivery.

Authors:  Sahar Rahmani; Astin M Ross; Tae-Hong Park; Hakan Durmaz; Acacia F Dishman; Diane M Prieskorn; Nathan Jones; Richard A Altschuler; Joerg Lahann
Journal:  Adv Healthc Mater       Date:  2015-07-14       Impact factor: 9.933

3.  Brain-derived neurotrophic factor promotes cochlear spiral ganglion cell survival and function in deafened, developing cats.

Authors:  Patricia A Leake; Gary T Hradek; Alexander M Hetherington; Olga Stakhovskaya
Journal:  J Comp Neurol       Date:  2011-06-01       Impact factor: 3.215

4.  Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons.

Authors:  Rachael T Richardson; Andrew K Wise; Brianna C Thompson; Brianna O Flynn; Patrick J Atkinson; Nicole J Fretwell; James B Fallon; Gordon G Wallace; Rob K Shepherd; Graeme M Clark; Stephen J O'Leary
Journal:  Biomaterials       Date:  2009-01-29       Impact factor: 12.479

5.  Effects of brain-derived neurotrophic factor (BDNF) and electrical stimulation on survival and function of cochlear spiral ganglion neurons in deafened, developing cats.

Authors:  Patricia A Leake; Olga Stakhovskaya; Alexander Hetherington; Stephen J Rebscher; Ben Bonham
Journal:  J Assoc Res Otolaryngol       Date:  2013-02-08

6.  Virally Mediated Overexpression of Glial-Derived Neurotrophic Factor Elicits Age- and Dose-Dependent Neuronal Toxicity and Hearing Loss.

Authors:  Omar Akil; Bas Blits; Lawrence R Lustig; Patricia A Leake
Journal:  Hum Gene Ther       Date:  2018-09-05       Impact factor: 5.695

7.  Drug delivery to the inner ear.

Authors:  Andrew K Wise; Lisa N Gillespie
Journal:  J Neural Eng       Date:  2012-11-27       Impact factor: 5.379

8.  Magnetic targeted delivery of dexamethasone acetate across the round window membrane in guinea pigs.

Authors:  Xiaoping Du; Kejian Chen; Satish Kuriyavar; Richard D Kopke; Brian P Grady; David H Bourne; Wei Li; Kenneth J Dormer
Journal:  Otol Neurotol       Date:  2013-01       Impact factor: 2.311

9.  Enhanced auditory neuron survival following cell-based BDNF treatment in the deaf guinea pig.

Authors:  Lisa N Pettingill; Andrew K Wise; Marilyn S Geaney; Robert K Shepherd
Journal:  PLoS One       Date:  2011-04-15       Impact factor: 3.240

10.  Enhanced bioavailability of nerve growth factor with phytantriol lipid-based crystalline nanoparticles in cochlea.

Authors:  Meng Bu; Jingling Tang; Yinghui Wei; Yanhui Sun; Xinyu Wang; Linhua Wu; Hongzhuo Liu
Journal:  Int J Nanomedicine       Date:  2015-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.